FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156463882> ?p ?o ?g. }

• W2156463882 endingPage "130" @default.
• W2156463882 startingPage "129" @default.
• W2156463882 abstract "<h3>Objectives</h3> Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific evidence to support such a role is lacking. We investigated whether users of the COVID-19 Symptom Study app who regularly took dietary supplements were less likely to test positive for SARS-CoV-2 infection. <h3>Design</h3> App-based community survey. <h3>Setting</h3> 445 850 subscribers of an app that was launched to enable self-reported information related to SARS-CoV-2 infection for use in the general population in the UK (n=372 720), the USA (n=45 757) and Sweden (n=27 373). <h3>Main exposure</h3> Self-reported regular dietary supplement usage (constant use during previous 3 months) in the first waves of the pandemic up to 31 July 2020. <h3>Main outcome measures</h3> SARS-CoV-2 infection confirmed by viral RNA reverse transcriptase PCR test or serology test before 31 July 2020. <h3>Results</h3> In 372 720 UK participants (175 652 supplement users and 197 068 non-users), those taking probiotics, omega-3 fatty acids, multivitamins or vitamin D had a lower risk of SARS-CoV-2 infection by 14% (95% CI (8% to 19%)), 12% (95% CI (8% to 16%)), 13% (95% CI (10% to 16%)) and 9% (95% CI (6% to 12%)), respectively, after adjusting for potential confounders. No effect was observed for those taking vitamin C, zinc or garlic supplements. On stratification by sex, age and body mass index (BMI), the protective associations in individuals taking probiotics, omega-3 fatty acids, multivitamins and vitamin D were observed in females across all ages and BMI groups, but were not seen in men. The same overall pattern of association was observed in both the US and Swedish cohorts. <h3>Conclusion</h3> In women, we observed a modest but significant association between use of probiotics, omega-3 fatty acid, multivitamin or vitamin D supplements and lower risk of testing positive for SARS-CoV-2. We found no clear benefits for men nor any effect of vitamin C, garlic or zinc. Randomised controlled trials are required to confirm these observational findings before any therapeutic recommendations can be made." @default.
• W2156463882 created "2016-06-24" @default.
• W2156463882 creator A5020711462 @default.
• W2156463882 date "2001-07-01" @default.
• W2156463882 modified "2023-10-02" @default.
• W2156463882 title "Accessory middle cerebral artery and moyamoya disease" @default.
• W2156463882 cites W1975647306 @default.
• W2156463882 cites W1978575021 @default.
• W2156463882 cites W2001705155 @default.
• W2156463882 cites W2031469293 @default.
• W2156463882 cites W2077234536 @default.
• W2156463882 cites W2103393014 @default.
• W2156463882 cites W2131989466 @default.
• W2156463882 cites W2132351131 @default.
• W2156463882 cites W2313825009 @default.
• W2156463882 cites W2346108732 @default.
• W2156463882 cites W2400840736 @default.
• W2156463882 doi "https://doi.org/10.1136/jnnp.71.1.129" @default.
• W2156463882 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1737469" @default.
• W2156463882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11439964" @default.
• W2156463882 hasPublicationYear "2001" @default.
• W2156463882 type Work @default.
• W2156463882 sameAs 2156463882 @default.
• W2156463882 citedByCount "17" @default.
• W2156463882 countsByYear W21564638822012 @default.
• W2156463882 countsByYear W21564638822013 @default.
• W2156463882 countsByYear W21564638822015 @default.
• W2156463882 countsByYear W21564638822016 @default.
• W2156463882 countsByYear W21564638822018 @default.
• W2156463882 countsByYear W21564638822022 @default.
• W2156463882 crossrefType "journal-article" @default.
• W2156463882 hasAuthorship W2156463882A5020711462 @default.
• W2156463882 hasBestOaLocation W21564638821 @default.
• W2156463882 hasConcept C126322002 @default.
• W2156463882 hasConcept C164705383 @default.
• W2156463882 hasConcept C171614378 @default.
• W2156463882 hasConcept C2775841333 @default.
• W2156463882 hasConcept C2776548475 @default.
• W2156463882 hasConcept C541997718 @default.
• W2156463882 hasConcept C71924100 @default.
• W2156463882 hasConceptScore W2156463882C126322002 @default.
• W2156463882 hasConceptScore W2156463882C164705383 @default.
• W2156463882 hasConceptScore W2156463882C171614378 @default.
• W2156463882 hasConceptScore W2156463882C2775841333 @default.
• W2156463882 hasConceptScore W2156463882C2776548475 @default.
• W2156463882 hasConceptScore W2156463882C541997718 @default.
• W2156463882 hasConceptScore W2156463882C71924100 @default.
• W2156463882 hasIssue "1" @default.
• W2156463882 hasLocation W21564638821 @default.
• W2156463882 hasLocation W21564638822 @default.
• W2156463882 hasLocation W21564638823 @default.
• W2156463882 hasLocation W21564638824 @default.
• W2156463882 hasOpenAccess W2156463882 @default.
• W2156463882 hasPrimaryLocation W21564638821 @default.
• W2156463882 hasRelatedWork W2319552265 @default.
• W2156463882 hasRelatedWork W2353638069 @default.
• W2156463882 hasRelatedWork W289392986 @default.
• W2156463882 hasRelatedWork W2947870409 @default.
• W2156463882 hasRelatedWork W3112874682 @default.
• W2156463882 hasRelatedWork W4210372172 @default.
• W2156463882 hasRelatedWork W4245417133 @default.
• W2156463882 hasRelatedWork W4248221996 @default.
• W2156463882 hasRelatedWork W1907664398 @default.
• W2156463882 hasRelatedWork W3200423780 @default.
• W2156463882 hasVolume "71" @default.
• W2156463882 isParatext "false" @default.
• W2156463882 isRetracted "false" @default.
• W2156463882 magId "2156463882" @default.
• W2156463882 workType "article" @default.